Elderly cancer patients should not be denied therapy based on age Comment 10 February 2013 Pages: 4 - 4
Rosiglitazone: clinical, economic gains in patients with type 2 DM Meeting report 10 February 2013 Pages: 4 - 4
Irbesartan cost effective in diabetic nephropathy with hypertension Clinical study 10 February 2013 Pages: 5 - 5
Benzodiazepines still preferred over SSRIs in panic disorder Clinical study 10 February 2013 Pages: 6 - 6
Disease burden profiles provide “credible estimates of future costs” Clinical study 10 February 2013 Pages: 6 - 6
HAART accounts for large increase in HIV/AIDS costs in Canada News item 10 February 2013 Pages: 6 - 6
Thiazide diuretic use in hypertension could save $US millions Clinical study 10 February 2013 Pages: 6 - 6
Drug addiction concerns constricting chronic lower back pain market Media release 10 February 2013 Pages: 7 - 7
Insulin use, disease complications raise costs in type 2 DM Clinical study 10 February 2013 Pages: 7 - 7
Linezolid vs vancomycin, oxacillin for cellulitis in the US Clinical study 10 February 2013 Pages: 7 - 7
Antibacterial use varies among paediatrics in Sweden, Denmark Clinical study 10 February 2013 Pages: 9 - 9
Postmenopausal breast cancer costs substantial in Belgium Clinical study 10 February 2013 Pages: 9 - 9
Reduced vibration detection predicts higher diabetic complication costs Clinical study 10 February 2013 Pages: 9 - 9
Costs, resource use significant in perennial allergic rhinitis Clinical study 10 February 2013 Pages: 10 - 10
Dextropropoxyphene use prevalent in US Medicare elderly Clinical study 10 February 2013 Pages: 10 - 10
AIDS Drugs Direct offers less costly drugs in the US, SA Media release 10 February 2013 Pages: 11 - 11
First-line colorectal cancer therapy market seized by oxaliplatin News item 10 February 2013 Pages: 11 - 11